Paying Up For A Good Property
Harris Teeter was widely known to be for sale, with multiple speculations in the financial press about which private equity groups had, or had not, placed bids for the growing mid-Atlantic chain of supermarkets. Accordingly, it's no great surprise that Kroger had to pay up to get a deal done.
Kroger will pay $49.38 per share in cash, and assume $100 million in Harris Teeter debt. Not only is that per-share price about one-third higher than where Harris Teeter was before word spread that the company was exploring a scale, but the EV/revenue and EV/EBTIDA multiples are well ahead of industry averages.
Top Up And Coming Companies To Buy Right Now: Metro Bancorp Inc(METR)
Metro Bancorp, Inc. operates as the bank holding company for Metro Bank, which provides a range of retail and commercial banking services to consumers and small and mid-sized companies in Pennsylvania. Its deposit products include personal and business checking accounts, regular savings accounts, money market accounts, interest checking accounts, fixed rate certificates of deposit, individual retirement accounts, and club accounts. The company?s loan products portfolio comprises commercial and industrial, owner occupied real estate, commercial construction and land development, and commercial real estate loans; consumer loans, including home equity, overdraft checking protection, and consumer credit cards, as well as installment loans for home improvement, and the purchase of consumer goods and automobiles; and construction loans and permanent mortgages for homes. It also offers debit card services, online banking services, safe deposit facilities, and automated teller fa cilities. As of July 14, 2011, Metro Bancorp operated 33 stores in the counties of Berks, Cumberland, Dauphin, Lancaster, Lebanon, and York. The company was formerly known as Pennsylvania Commerce Bancorp, Inc. and changed its name to Metro Bancorp, Inc. in June 2009. Metro Bancorp, Inc. was founded in 1984 and is headquartered in Harrisburg, Pennsylvania.
Advisors' Opinion:- [By Tim Melvin]
Metro Bancorp (METR) is one bank that might consider selling based on these metric. The company�� return on assets has consistently been well below its peer group, and the equity-to-asset ratio is just 8.46 — well below the 11 average across the United States.
Top 5 Supermarket Companies To Invest In 2015: Resolute Energy Corporation(REN)
Resolute Energy Corporation, an independent oil and gas company, engages in the acquisition, exploration, exploitation, and development of oil and gas properties in the United States. It primarily holds interests in the Aneth Field properties that cover approximately 43,000 gross acres on the Navajo Reservation in southeast Utah. The company? producing properties are located in the Powder River Basin, Wyoming; the Bakken shale trend of the Williston Basin in North Dakota; and the Permian Basin of Texas It also owns exploration properties in the Permian Basin of Texas; and the Big Horn and Powder River Basins of Wyoming. As of December 31, 2011, the company had estimated net proved reserves of approximately 64.8 million equivalent barrels of oil. Resolute Energy Corporation is based in Denver, Colorado.
Advisors' Opinion:- [By Monica Gerson]
Resolute Energy (NYSE: REN) is projected to report its Q4 earnings at $0.04 per share on revenue of $89.46 million.
Perfect World Co (NASDAQ: PWRD) is expected to post its Q4 earnings at $0.43 per share on revenue of $142.11 million.
- [By Lisa Levin]
Resolute Energy (NYSE: REN) shares fell 1.63% to reach a new 52-week low of $7.25. Resolute Energy shares have dropped 33.84% over the past 52 weeks, while the S&P 500 index has gained 20.12% in the same period.
- [By Garrett Cook]
In trading on Wednesday, energy shares were relative leaders, up on the day by about 0.59 percent. Top gainers in the sector included Parker Drilling Co (NYSE: PKD), Alpha Natural Resources (NYSE: ANR), and Resolute Energy (NYSE: REN).
Top 5 Supermarket Companies To Invest In 2015: Progress Energy Inc.(PGN)
Progress Energy, Inc., a utility holding company, engages in the generation, transmission, distribution, and sale of electricity in North Carolina, South Carolina, and Florida. It uses coal, oil, hydroelectric, natural gas, and nuclear power to generate electricity. The company also engages in various alternative energy projects to generate electricity from swine waste and other plant or animal sources, biomass, solar, hydrogen, and landfill-gas technologies. Progress Energy serves various industries, including chemicals, textiles, paper, food, metals, wood products, rubber and plastics, and stone products, as well as phosphate rock mining and processing, electronics design and manufacturing, and citrus and other food processing. It has approximately 22,000 megawatts of regulated electric generation capacity and serves approximately 3.1 million retail electric customers, as well as other load-serving entities. The company was formerly known as CP&L Energy, Inc. Progress En ergy, Inc. was founded in 1925 and is headquartered in Raleigh, North Carolina.
Advisors' Opinion:- [By Ben Levisohn]
We expect Caledonia to generate close to $600M in EBITDA. While RIGs mid-water OPEX has averaged about $125k/d we expect it to be lower at Caledonia. 2015 Consensus EBITDA for RIG is ~$3B which means 20% of RIGs 2015 EBITDA comes from the rigs that will become Caledonia. The problem (in a bear market) is that companies with lower end rigs trade at a discount ��just ask Awilco (AWLCF), Fred Olsen Energy, and Paragon Offshore (PGN) which trade at an average multiple of 3.3x on 2015 EBITDA versus RIG which trades at 6.3x.
- [By Holly LaFon] ess Energy shares climbed over 2011 as the company announced in January it would merge with Duke Energy. Together, they will form the nation�� largest utility with a combined enterprise value of $65 billion and $37 billion in market cap. The new company will have 57 gigawatts of domestic generating capacity through a mix of coal, nuclear, natural gas, oil and renewable resources. Progress energy shareholders will receive an approximately 3 percent dividend increase.
Incidentally, development of a comprehensive energy policy was one of what Grantham called ��he most important and most dangerous issues��facing the world.
Progress is at the forefront of the push for nuclear energy in the U.S., which has been deemed the ��uclear renaissance.��Thirty-five percent of the electricity used by Progress Energy customers comes from one of their four nuclear sites, two in North Carolina, and one each in South Carolina and Florida. It plans to build another reactor in Levy County, Florida.
Revenue at Progress Energy has declined at a 2.6% annual rate over the past five years, and it achieved cash flow of $95 million in 2010, after three years of losses. Earnings have remained positive, reaching a record for the decade of $856 million in 2010.
RSC Holdings (RRR)
RSC is a machinery rental service for construction, industrial, petrochemical, governmental and manufacturing businesses in the U.S. and Canada. RSC tends to benefit in economic downturns, as more businesses turn to renting rather than buying equipment to cut costs. Rented equipment rose 20.7% percent (the sixth consecutive quarter of double-digit growth) and rental revenue increased 27% in the fourth quarter of 2011, compared to last year.
United Rentals (URI), one of RSC�� largest competitors, had a rental revenue increase of 18.5% in the fourth quarter compared to last year, which included a 6.7% increase in rental rates.
The company�� fleet utilization also
Top 5 Supermarket Companies To Invest In 2015: Elite Pharmaceuticals Inc (ELTP)
Elite Pharmaceuticals, Inc. (Elite), incorporated on October 1, 1997, is a specialty pharmaceutical company principally engaged in the development and manufactures of oral, controlled-release products, using technology and the development and manufacture of generic pharmaceuticals. Elite has four products: Phentermine 37.5 milligram tablets, Methadone 10 milligram tablets, Lodrane D Immediate Release capsules and Hydromorphone Hydrochloride 8 milligram tablets. During the fiscal years ended March 31, 2012 (Fiscal 2011), the Company manufactured and sold Lodrane 24 and Lodrane 24D (the Lodrane Extended Release Products).
The Company has a pipeline of additional generic drug candidates under active development, including, without limitation, ELI-154, a once-a-day oxycodone product and ELI-216, an abuse resistant oxycodone product which utilizes the Company�� propriety formulation for abuse resistant products utilizing the pharmacological approach (Elite�� Abuse Resistant Technology). ECR Pharmaceuticals (ECR), a wholly owned subsidiary of Hi-Tech Pharmacal, Inc. and the owner and marketer of the Lodrane Extended Release Products. Elite also purchased from Mikah Pharma LLC, an approved Abbreviated New Drug Application (ANDA) for Naltrexone 50 milligram tablets.
For ELI-154, Elite has developed a once-daily oxycodone formulation using its technology. An investigational new drug application (IND) has been filed and Elite has completed two pharmacokinetic studies in healthy subjects that compared blood levels of oxycodone from dosing ELI-154 and the twice-a-day product that is on the market, OxyContin marketed in the United States by Purdue Pharma LP. ELI-216 utilizes the Company's abuse-deterrent technology that is based on a pharmacological approach. ELI-216 is a combination of a narcotic agonist, oxycodone hydrochloride, in a sustained-release formulation intended for use in patients with moderate to severe chronic pain, and an antagonist, naltrexone hydrochloride, formulat! ed to deter abuse of the drug. Products utilizing the pharmacological approach to deter abuse such as Suboxone, a product marketed in the United States by Reckitt Benckiser Pharmaceuticals, Inc., and Embeda, a product marketed in the United States by Pfizer, have been approved by the United States Food & Drug Administration (FDA). ELI-216 demonstrates a euphoria-blocking effect when the product is crushed. Elite has developed ELI-154 and ELI-216 and retains the rights to these products.
The Company competes with Collegium Pharmaceuticals, Inc., Purdue Pharma LP, Acura Pharmaceuticals, Inc., Durect Corporation, Mylan Laboratories, Inc., Par Pharmaceuticals, Inc., Alkermes, Inc., Teva Pharmaceuticals Industries Ltd., Aptalis Pharma, Impax Laboratories, Inc., and Watson Pharmaceuticals.
Advisors' Opinion:- [By James E. Brumley]
Judging from the company it's keeping Green Automotive Co. (OTCMKTS:GACR) may have just made its way into the upper echelon of small cap stock opportunities. The electric car company joins Elite Pharmaceuticals Inc. (OTCBB:ELTP), Amarantus Bioscience Holdings, Inc. (OTCBB:AMBS), and only three other companies as Wall-Street.com's "Best 6 Stocks" for January of 2014. As one of the top information resources for investors - particularly in terms of information regarding small and micro cap stocks - being named among the site's top pick is an accolade for AMBS, ELTP, and GACR. Even more impressive is that Green Automotive Co. was the only consumer-goods name among those six. Amarantus Bioscience Holdings and Elite Pharmaceuticals are biotechnology names... an industry that can and often does attract a lot of attention just by the nature of the business. The other three names making the "Best 6" list were an energy explorer, a power-management technology manufacturer, and prescription/medical food producer. For an electric car manufacturer to make the list speaks quite highly of GACR.
- [By James E. Brumley]
Exactly one month ago today I penned some bullish thoughts on Elite Pharmaceuticals Inc. (OTCBB:ELTP). If you're familiar with the company - or a regular reader of this site - then you may know why that sounds a little "off." See, at the time, ELTP shares were falling rather quickly, giving up all the gains they had made just a few days before. Almost needless to say, my premise was not a well received one. Let's just say I received some "colorful disagreements" by being optimistic about the biopharma company.
- [By CRWE]
Today, ELTP has shed (-8.01%) down -0.009 at $.101 with 4,629,899 shares in play thus far (ref. google finance Delayed: 1:00PM EDT September 16, 2013).
Elite Pharmaceuticals, Inc. previously reported the first quarter of fiscal year 2014 ended June 30, 2013. Manufacturing and profit split revenues comprised almost all of Elite’s quarterly revenues and totaled $717k for the quarter, an increase of 41% from the prior year. This growth is attributed to the launch of two new products during the quarter, Phentermine 15mg and 30mg capsules, combined with strong year-on-year growth of the Elite’s Hydromorphone 8mg tablets and contract manufactured Methadone 10mg product lines.
No comments:
Post a Comment